Clinical Trial Update: Peposertib and Radiation Therapy, Followed by Temozolomide for the Treatment of Patients With Newly Diagnosed MGMT Unmethylated Glioblastoma or Gliosarcoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating peposertib with radiation therapy followed by temozolomide for newly diagnosed MGMT unmethylated glioblastoma or gliosarcoma; recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Gliosarcoma

Drugs mentioned

• Peposertib (Peposertib)
• Temozolomide (Temozolomide)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Glioblastoma, Gliosarcoma | Phase 1 | Status: RECRUITING